No Data
Express News | gansu longshenrongfa pharmaceutical industry: obtained a new pharmaceutical production license and passed the GMP inspection.
Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ): Not involving drugs for the prevention and control of nuclear pollution.
On November 26, Gelonghui reported that gansu longshenrongfa pharmaceutical industry (300534.SZ) stated on the investor interaction platform that the company is not involved in drugs for nuclear pollution prevention. The health food currently produced, "Astragalus Angelica Capsules," is based on gansu authentic medicinal materials, using the food and medicine homologous ingredients astragalus and angelica. It is derived from ancient famous prescriptions and has clear effects in anti-radiation, replenishing qi and blood, and enhancing immunity. The formula of "Astragalus Angelica Capsules" was developed in response to market demand for health food to improve radiation injury, mainly targeting people who work in radiation environments for a long time, focusing on the function of improving radiation damage, based on traditional Chinese medicine health theories.
Longshenrongfa Pharmaceutical Industry's Research Institute Chosen for Gansu Province's Engineering Centers List
Gansu longshenrongfa pharmaceutical industry (300534.SZ): The company's R&D platform has been selected for the Gansu provincial 2024 provincial engineering research center optimization and integration list.
On November 20, Gelonghui reported that gansu longshenrongfa pharmaceutical industry (300534.SZ) announced that the Gansu Provincial Development and Reform Commission recently issued the "Notice on the Issuance of the List of Newly Identified and Optimized and Integrated Provincial Engineering Research Centers for 2024". Based on the existing "Gansu Province Traditional Chinese Medicine New Drug Dosage Form Research Engineering Laboratory", the company applied for the optimization, integration, and construction of the "Gansu Provincial Drug Formulation Technology and Industrialization Engineering Research Center", which was selected for the Gansu Province 2024 Provincial Engineering Research Center Optimization and Integration List.
Longshen Rongfa: Report for the third quarter of 2024
Express News | gansu longshenrongfa pharmaceutical industry: net income in the first three quarters was 24.7672 million yuan, a year-on-year decrease of 47.11%.
No Data
No Data